Anahuac University School of Medicine, Mexico. M.D. Cum Laude
Research trainee, Mayo Clinic
Residency: Internal Medicine, University of Minnesota
Fellowship: Hematology and Oncology, Mayo Clinic College of Medicine
Research interests include health services research, where the main goal is to understand how patients are treated in the general population (who do not have access to cancer centers) and learning how the most recent advances might be brought to treating these individuals. Also working to design and implement clinical trials that might establish a new, life-saving treatment. Another recent focus is on strategies to harness the immune system in treating virus-associated cancers.
Dr. Santana-Davila is a medical oncologist who is board certified in Internal Medicine and in Hematology/Oncology. He specializes in treating patients with lung and head-and-neck cancers, and also has experience in treating patients with breast, gastric and hematologic cancers.
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma, NSCLC or Transitional Cell Carcinoma of the Urothelium